Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Religare Enterprises...

    Religare Enterprises inducts three new board members

    Written by Ruby Khatun Khatun Published On 2018-02-19T11:02:36+05:30  |  Updated On 19 Feb 2018 11:02 AM IST
    Religare Enterprises inducts three new board members

    New Delhi: Diversified financial services firm Religare Enterprises said it has inducted three new board members and plans to raise Rs 1,200 crore through a mix of equity and debt.


    The announcement comes close on the heels of the resignation of promoters Malvinder Mohan Singh and Shivinder Mohan Singh from the board earlier this week. Malvinder Mohan Singh had stepped down as CEO of the firm in November.


    Read also: Singh brothers resign from board of Religare Enterprises

    The three new members are Vikram Talwar, an experienced banker and entrepreneur; P Vijaya Bhaskar, retired Executive Director of the Reserve Bank of India; and Siddharth Mehta, the founder of Bay Capital Partners, Religare said in a statement.


    Mehta has been appointed as interim CEO, while Vijaya Bhaskar will chair the Audit Committee, it said, adding the search for a full-time CEO and other senior management is being started on an immediate basis.


    The company also announced plans to raise additional funds of up to Rs 1,200 crore for investments to bolster its capital and to make investments in subsidiaries as required. A special sub-committee of the board comprising the three new board members has been appointed to review the entire business of the company and any specific governance issues. Sub-committees of the board for audit, risk, corporate governance and compensation have also been reconstituted, it said.


    The statement said the board intends to establish a clear long-term strategy for the company with the objectives of ensuring financial stability, prudent growth and strong profitability.

    board membersCEOinductsMalvinder Mohan SinghP Vijaya BhaskarReligare EnterprisesresignationShivinder Mohan SinghSiddharth MehtaVikram Talwar
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok